Market Research Logo

»»

US Product Portfolio for Dental Bone Graft Substitutes and Other Biomaterials 2017 - MedFolio

Lowest Prices Guaranteed Length Publisher Published Date SKU
from $1,995 206 Pages iData Research, Inc. July, 2017 IDR15407790
Lowest Prices Guaranteed
Price from $1,995
Length 206 Pages
Publisher iData Research, Inc.
Published Date July, 2017
SKU IDR15407790
$1,995
$2,394
$2,992.50
 
Research assistance
US: 800.298.5699
Int'l: +1.240.747.3093

US Product Portfolio for Dental Bone Graft Substitutes and Other Biomaterials 2017 - MedFolio

General Report Contents

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions
A major limiter preventing market growth in the dental bone graft substitute and other biomaterials markets is the tendency to supplement large-scale implant purchases with discounted, and even complimentary, DBGS materials. As periodontists and oral surgeons outnumber general practitioners (GPs) in terms of dentists placing implants in the United States, and as these specialists tend to buy in bulk, this trend is expected to persist in the future.

The growing number of GPs placing implants is driving the total markets for dental bone graft substitutes and other biomaterials forward by increasing the volume of dental implant procedures. Another result of more GPs trained on implants is that they are more knowledgeable over the critical factors necessary to achieve a successful implant procedure. Therefore, the increased number of GPs placing implants increases the probability that a patient is informed on the importance of having a sufficient level of bone in their jaw prior to the procedure. Ultimately, this will result in a greater number of patient referrals to specialists for dental regenerative procedures that incorporate either a DBGS and membrane or a dental growth factor.

As in previous years, pre-existing materials within the market continue to be improved. Improvements are being made to every segment of the DBGS market. With regards to digital systems, the high growth rate of the dental implant industry has spurred the development and greater acceptance of technologies in the dental market that assist in greater efficiency in restoring dental implants; these technological advances, in turn, drive further placement of implants as they offer dentists greater assistance. The greater utilization of cone beam computed tomography (CBCT) scanners, which are modified versions of traditional CT scanners for dental applications, assists in designing accurate three-dimensional models of a patient’s jaw. Based on the three-dimensional model, imaging software can be used to diagnose the bone density and structure of the patient’s jaw structure that will provide much greater insight into the condition of the patient’s jaw. With regards to dental growth factors, the market is moving towards improving the convenience of handling the products. Handling characteristics are essential features of dental growth factor products. Due to their chemical and biological composition, these products are easier to apply than conventional bone graft materials. These products are often provided in a liquid format, allowing them to be combined with bone graft substitutes by end-users to suit their purposes. The current exception to this is Osteocel®, which must be kept frozen until ready for use.

The full report suite on the U.S. market for dental bone graft substitutes (DBGS) and other biomaterials includes dental bone graft substitutes, dental growth factors and dental barrier membranes.


EXECUTIVE SUMMARY
U.S. DENTAL BONE GRAFT SUBSTITUTES AND OTHER BIOMATERIALS MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURES COVERED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.1.1 Dental Anatomy: Oral Cavity and Intraoral landmarks
2.2 DISEASE PATHOLOGY AND DISORDERS
2.2.1 General Diagnostics
2.2.2 Indication for Dental Implant
2.2.2.1 Periodontal Disease
2.2.2.2 Dental Implant Procedures
2.3 PATIENT DEMOGRAPHICS
2.3.1 General Dental Statistics
2.3.2 Tooth Loss Statistics
PRODUCT ASSESSMENT
3.1 PRODUCT PORTFOLIOS
3.1.1 Dental Bone Graft Substitutes
3.1.1.1 Autografts
3.1.1.2 Allografts
3.1.1.3 Xenografts
3.1.1.4 Synthetics
3.1.1.5 Dental Barrier Membranes
3.1.1.6 Dental Growth Factor Products
3.2 REGULATORY ISSUES AND RECALLS
3.2.1 Dental Bone Graft Substitutes
3.3 CLINICAL TRIALS
3.3.1 Dental Bone Graft Substitutes
ABBREVIATIONS
APPENDIX: COMPANY PRESS RELEASES
List of Charts
Chart 1 1: Dental Bone Graft Substitutes and Other Biomaterials Market by Segment, U.S., 2013 – 2023
Chart 1 2: Dental Bone Graft Substitutes and Other Biomaterials Market Overview, U.S., 2016 & 2023
List of Figures
Figure 1 1: Dental Bone Graft Substitutes and Other Biomaterials Market Share Ranking by Segment, U.S., 2016
Figure 1 2: Companies Researched in this Report, U.S., 2016
Figure 1 3: Factors Impacting the Dental Bone Graft Substitutes and Other Biomaterials Market by Segment, U.S.
Figure 1 4: Recent Events in the Dental Bone Graft Substitutes and Other Biomaterials Market, U.S., 2013 – 2016
Figure 1 5: Dental Bone Graft Substitutes and Other Biomaterials Markets Covered, U.S., 2016
Figure 1 6: Dental Bone Graft Substitutes and Other Biomaterials Markets Covered, U.S., 2016 (1 of 2)
Figure 1 7: Dental Bone Graft Substitutes and Other Biomaterials Markets Covered, U.S., 2016 (2 of 2)
Figure 1 8: Key Report Updates
Figure 1 9: Version History
Figure 3 1: Dental Bone Graft Substitute Products by Company (1 of 2)
Figure 3 2: Dental Bone Graft Substitute Products by Company (2 of 2)
Figure 3 3: Dental Barrier Membrane Products by Company (1 of 2)
Figure 3 4: Dental Barrier Membrane Products by Company (2 of 2)
Figure 3 5: Dental Growth Products by Company
Figure 3 6: Class 3 Device Recall ZCORE Syringe
Figure 3 7: Class 2 Device Recall Collagen Matrix Inc.
Figure 3 8: Class 2 Device Recall Endobon Xenograft Granules, Biomet France SARL
Figure 3 9: Class 3 Device Recall ENDOBON XENOGRAFT GRANULES 0.5 ML
Figure 3 10: Effect of Mucograft® Seal on Post-extraction Ridge Preservation Using Bone Allograft (Mucograft)
Figure 3 11: Prospective, Comparative Assessment of Alveolar Bone Augmentation Using GUIDOR® Membrane
Figure 3 12: Evaluation of Zimmer Puros® Allograft vs. Creos™ Allograft for Alveolar Ridge Preservation
Figure 3 13: Guided Bone Regeneration Using Synthetic Membrane
Figure 3 14: Histological Comparison of Ridge Preservation Using Mineralized FDBA Alone Versus a Combined Mineralized-Demineralized Freeze Dried Bone Allograft
Figure 3 15: A Randomized Control Trial Testing Connective Tissue Grafts vs. Allograft on Dental Implants
Figure 5 1: Press Release Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

Other tasks